Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0237 Transporter Info | ||||
Gene Name | SLC26A9 | ||||
Transporter Name | Anion transporter/exchanger protein 9 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
Benzo(a)pyrene results in decreased methylation of SLC26A9 3' UTR | [12] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Benzo(a)pyrene results in increased methylation of SLC26A9 promoter | [12] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
abrine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
abrine results in decreased expression of SLC26A9 mRNA | [11] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
butyraldehyde |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
butyraldehyde results in decreased expression of SLC26A9 mRNA | [4] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
CGP 52608 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
CGP 52608 promotes the reaction RORA protein binds to SLC26A9 gene | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Lactic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Lactic Acid results in decreased expression of SLC26A9 mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Okadaic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Okadaic Acid results in decreased expression of SLC26A9 mRNA | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Oxalates |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
SLC26A9 affects the reaction Oxalates results in increased expression of MUC5AC mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
SLC26A9 affects the reaction Oxalates results in increased expression of SPDEF mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Silicon Dioxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Silicon Dioxide analog results in decreased expression of SLC26A9 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Valproic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid results in increased methylation of SLC26A9 gene | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Mycotoxins |
|||||
Zearalenone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zearalenone results in decreased expression of SLC26A9 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Zidovudine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zidovudine increases the expression of SLC26A9 | [2] | |||
Doxorubicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Doxorubicin inhibits the expression of SLC26A9 | [3] | |||
Drug in Phase 3 Trial |
|||||
Triclosan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Triclosan inhibits the expression of SLC26A9 | [7] | |||
Drug in Preclinical Test |
|||||
(+)-JQ1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
(+)-JQ1 inhibits the expression of SLC26A9 | [6] | |||
Investigative Drug |
|||||
4,4''-diisothiocyanato-stilbene-2,2''-disulfonic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
4,4''-diisothiocyanato-stilbene-2,2''-disulfonic acid inhibits the transportation of Chloride ion by SLC26A9 | [1] | |||
Affected Drug/Substrate |
Chloride ion | Modulation Type | Inhibition | ||
NS 3623 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NS 3623 inhibits the transportation of Chloride ion by SLC26A9 | [1] | |||
Affected Drug/Substrate |
Chloride ion | Modulation Type | Inhibition | ||
Milchsaure |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Milchsaure inhibits the expression of SLC26A9 | [8] | |||
Natural Product |
|||||
Tobacco Smoke Pollution |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tobacco Smoke Pollution increases the expression of SLC26A9 | [10] | |||
Carcinogen |
|||||
Benzo(a)pyrene |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene inhibits the expression of SLC26A9 | [9] | |||
Health and Environmental Toxicant |
|||||
Butyraldehyde |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Butyraldehyde inhibits the expression of SLC26A9 | [4] | |||
tris(1,3-dichloro-2-propyl)phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of SLC26A9 | [5] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.